Article Details
Retrieved on: 2024-11-03 18:12:33
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses promising stocks under $100, such as AstraZeneca, Exelixis, and Summit Therapeutics, while highlighting Netflix's significant past returns as a successful "Double Down" example. The tags reflect the article's focus on biotech stocks and trading.
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here